Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Buy
58
SMMT Quote, Financials, Valuation and Earnings
Last price:
$24.41
Seasonality move
:
8.71%
Day range:
$23.45 - $24.45
52-week range:
$2.10 - $36.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18,562.29x
P/B ratio:
52.61x
Volume:
1.8M
Avg. volume:
5.4M
1-year change:
437.22%
Market cap:
$18.1B
Revenue:
--
EPS (TTM):
-$0.35
SMMT Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Summit Therapeutics shares anticipate an average target of $37.53, ranging from a low estimate of $30.15 to a high estimate of $44.21. This average target implies a growth of 53.14% compared to the current stock price of $24.39.
Consensus Price Target
$37.53
Highest Price Target
$44.21
Lowest Price Target
$30.15
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 1 | 6 | 7 |
| Hold | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Leans Bullish | Buy | Buy |
SMMT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
